Bank of New York Mellon to Redeem Senior Bank Notes Due 2025-February 2024-www.financetom.com

Bank of New York Mellon to Redeem Senior Bank Notes Due 2025

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Bank of New York Mellon to Redeem Senior Bank Notes Due 2025

Nov 13, 2024 9:35 AM

09:05 AM EST, 11/13/2024 (MT Newswires) -- Bank of New York Mellon ( BK ) said Wednesday that a wholly-owned subsidiary will redeem all $750 million of its issued and outstanding 5.224% fixed-to-floating rate callable senior bank notes due Nov. 21, 2025.

The notes will be redeemed on Nov. 21 at a price equal to 100% of the principal amount, plus any accrued and unpaid interest, the lender said.

Previous page： Dow's Q4 Earnings, Net Sales Decline Next page： Dow misses fourth quarter profit estimates, to lay off 1,500 employees

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Dow's Q4 Earnings, Net Sales Decline

Jan 30, 2025

06:14 AM EST, 01/30/2025 (MT Newswires) -- Dow (DOW) said Thursday it broke even in Q4, compared with operating earnings of $0.43 per share a year earlier. Analysts polled by FactSet expected $0.22. Net sales for the quarter ended Dec. 31 was $10.41 billion, down from $10.62 billion a year earlier. Analysts surveyed by FactSet expected $10.51 billion. ...

Dow misses fourth quarter profit estimates, to lay off 1,500 employees

Jan 30, 2025

Jan 30 (Reuters) - Chemical firm Dow missed fourth-quarter profit estimates on Thursday, and said it will lay off 1,500 employees globally. The chemical industry has been struggling with weak demand recovery, especially in Europe, where a challenging regulatory environment has led some companies to rethink their strategies. Last year, Dow announced it had begun reviewing some of its European...

Cargo Therapeutics to Cut Workforce by 50%, Discontinue Lymphoma Treatment Study -- Shares Down Pre-Bell

Jan 30, 2025

06:14 AM EST, 01/30/2025 (MT Newswires) -- Cargo Therapeutics ( CRGX ) said Wednesday that it will discontinue the phase 2 study of firicabtagene autoleucel, or firi-cel, for patients with large B-cell lymphoma, and reduce its workforce by about 50% to preserve cash for the development of other product candidates. The company said results from an ad-hoc analysis of the...

Thermo Fisher Scientific's Q4 Adjusted Earnings, Revenue Rise

Jan 30, 2025

06:09 AM EST, 01/30/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported Q4 adjusted earnings Thursday of $6.10 per diluted share, up from $5.67 a year earlier. Analysts polled by FactSet expected $5.94. Revenue for the quarter ended Dec. 31 was $11.40 billion, compared with $10.89 billion a year earlier. Analysts surveyed by FactSet expected $11.28 billion. ...